Reviving the promise of transcription factor Nrf2-based therapeutics for kidney diseases.

Item

http://www.wikidata.org/entity/Q42327949

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Reviving the promise of transcription factor Nrf2-based therapeutics for kidney diseases.

@en

Reviving the promise of transcription factor Nrf2-based therapeutics for kidney diseases.

@nl

type

Item

label

Reviving the promise of transcription factor Nrf2-based therapeutics for kidney diseases.

@en

Reviving the promise of transcription factor Nrf2-based therapeutics for kidney diseases.

@nl

prefLabel

Reviving the promise of transcription factor Nrf2-based therapeutics for kidney diseases.

@en

Reviving the promise of transcription factor Nrf2-based therapeutics for kidney diseases.

@nl

P1476

Reviving the promise of transcription factor Nrf2-based therapeutics for kidney diseases.

@en

P2093

Abdel R A Hamad

http://www.w3.org/2001/XMLSchema#string

Hamid Rabb

http://www.w3.org/2001/XMLSchema#string

Sanjeev Noel

http://www.w3.org/2001/XMLSchema#string

P2860

Bardoxolone methyl and kidney function in CKD with type 2 diabetes.

Succination of Keap1 and activation of Nrf2-dependent antioxidant pathways in FH-deficient papillary renal cell carcinoma type 2.

Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl.

Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury.

Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARγ, and HO-1.

T Lymphocyte-Specific Activation of Nrf2 Protects from AKI.

Integrated transcriptomic and proteomic analyses uncover regulatory roles of Nrf2 in the kidney.

The Nrf2 triterpenoid activator, CDDO-imidazolide, protects kidneys from ischemia-reperfusion injury in mice.

Systemic inflammation and oxidative stress in hemodialysis patients are associated with down-regulation of Nrf2.

Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice.

P2888

ki.2015.328

P304

1217-1218

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/KI.2015.328

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

286447604

http://www.w3.org/2001/XMLSchema#string

P698

26649656

http://www.w3.org/2001/XMLSchema#string

P932

5267352

http://www.w3.org/2001/XMLSchema#string